Nataf, Israel

Dalia Megiddo

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Nataf, IL (2014 - 2021)
  • M.P. Judean Hills, IL (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Dalia Megiddo: Innovator in Medical Treatments

Introduction

Dalia Megiddo, an accomplished inventor based in Nataf, Israel, has made significant contributions to the field of medical treatments, particularly in addressing critical health challenges. With a remarkable portfolio of 15 patents, her work focuses on innovative solutions for diseases associated with protein aggregation and opioid overdose.

Latest Patents

Among her latest patents is a groundbreaking method for the treatment of myopathic and neurodegenerative diseases through parenteral administration of trehalose. This patent discloses a pharmaceutical formulation that parenterally administers trehalose as a means of addressing diseases linked to abnormal protein aggregation. Additionally, she has developed a dry powder composition aimed at intranasal delivery, specifically for administering opioid receptor antagonists. This innovative formulation includes naloxone and is designed for the treatment of opioid overdose and related symptoms, showcasing her commitment to improving patient outcomes in critical situations.

Career Highlights

Dalia Megiddo has worked with notable companies such as Alcobra Ltd. and Seelos Therapeutics, Inc., where her innovative contributions have been instrumental in advancing medical treatment options. Her extensive experience in the pharmaceutical industry highlights her role as a key inventor and innovator in therapeutic solutions.

Collaborations

Throughout her career, Dalia has collaborated with esteemed professionals in the field, including her coworkers Rina Yamin and Yaron Ilan. These collaborations reflect her ability to work effectively within teams to foster innovation and drive impactful research.

Conclusion

Dalia Megiddo’s dedication to innovation in medical treatments, evidenced by her extensive patent portfolio and collaborative projects, positions her as a leading figure in the research and development of life-saving pharmaceuticals. As she continues to advance her work, the medical community eagerly anticipates the potential impacts of her inventions on patient health and wellness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…